Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

BoNTANA Therapies describes nucleic acids encoding botulinum neurotoxins

Sep. 13, 2019

Genentech describes lead small-molecule IRAK-4 inhibitors

Sep. 9, 2019

Phase III TULIP 2 trial of anifrolumab in SLE meets primary endpoint

Aug. 29, 2019

For proinflammatory antibody, too much of a bad thing is a good thing

Aug. 29, 2019

Bristol-Myers Squibb presents discovery of lupus candidate BMS-615

Aug. 28, 2019

FDA grants approval for Taltz as treatment of active ankylosing spondylitis

Aug. 27, 2019

Medshine Discovery identifies Janus kinase inhibitors

Aug. 23, 2019

Identifying the cause of lupus cognitive dysfunction

Aug. 22, 2019

Placental growth factor may be autoimmune disease target

Aug. 22, 2019

PI3K-alpha tested as a therapeutic target for prevention of heterotopic ossification

Aug. 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...